CXCL8 and prostate carcinoma: To date, increasing number of studies indicated that CXCL8 and its receptors were overexpressed in several types of human cancers, including colorectal cancer [17], prostate cancer [18], cervical cancer [19] and non-small cell lung cancer [20].